NCT04009668 2024-10-30Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change DiseaseUniversity of MichiganPhase 2 Completed7 enrolled 12 charts
NCT01024036 2018-03-21A Study to Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's DiseaseJanssen Research & Development, LLCPhase 2 Completed79 enrolled 20 charts